Hrt Financial LP Trans Medics Group, Inc. Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$70.86 - $89.93 $606,490 - $769,710	8,559 New	8,559 $632,000
Q3 2023 Nov 13, 2023	SELL	$53.47 - $96.07 $218,157 - $391,965	-4,080 Reduced 42.87%	5,438 $297,000
Q2 2023 Aug 11, 2023	SELL	$66.23 - $88.73 $904,635 - $1.21 Million	-13,659 Reduced 58.93%	9,518 $799,000
Q1 2023 May 12, 2023	BUY	$53.63 - $82.33 $914,927 - $1.4 Million	17,060 Added 278.89%	23,177 $1.76 Million
Q4 2022 Feb 10, 2023	BUY	$39.08 - $64.29 $239,052 - $393,261	6,117 New	6,117 $377,000
Q3 2021 Nov 15, 2021	SELL	$25.92 - $34.51 $226,566 - $301,651	-8,741 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$21.63 - $40.07 $189,067 - $350,251	8,741 New	8,741 $290,000

391

31.3M

466K

286K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.13B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.